Doctors can already aptly diagnose Alzheimer's when certain significant symptoms are presents, like memory loss, vision problems and confusion, but these occur when the condition has worsened substantially. But now, a breakthrough research is busy looking for the brain mechanisms of the condition when it is in its earliest stages, which would increase the potential for timely intervention and boost the chances of better treatment.

As many as two different studies published during this week alone might just help pave the way for better treatments of people with Alzheimer's, a condition which affects an estimated 5.3 million Americans, according to the Alzheimer's Association.

One method is a drink that people will be able to simply pick up from a pharmacy and the other is a detection method.

Scientists have managed to develop a drink called Souvenaid that is a "medical food", and its study conducted has managed to provide with substantial results to suggest that it could help with early Alzheimer's diagnosis.

Scanning for early sings is another way to catch the condition in its preliminary stages.

The papers have been published n the journal Alzheimer's & Dementia.